Speaker Profile

BIOGRAPHY

Dr S. Leigh Verbois, Ph.D., is the Lead for Global Regulatory and Laboratory Programs at the U.S. Pharmacopoeia (USP), where she oversees the conceptualization and implementation of the organization’s global regulatory and laboratory growth strategies. She provides technical oversight for related programmatic activities and leads efforts to strengthen supply chain resiliency initiatives both in the United States and internationally.

Dr Verbois brings extensive global and supply chain experience gained during her distinguished career at the U.S. Food and Drug Administration (FDA). Most recently, she served as Director of the Office of Drug Security, Integrity, and Response within CDER’s Office of Compliance, where she provided strategic leadership for pharmaceutical import and export oversight, product recalls, and supply chain compliance and enforcement programmes.

Throughout her FDA tenure, Dr Verbois held several senior leadership positions, guiding the agency’s international operations, policy formulation, and diplomatic engagements aimed at safeguarding global public health. Her previous roles include Director of the Office of Global Operations within the Office of Global Policy and Strategy; Acting Assistant Commissioner for International Programs; FDA Country Director for the People’s Republic of China in Beijing; and Director of the Office of Regional and Country Affairs, where she oversaw FDA’s regulatory engagement with countries across the Asia-Pacific region (excluding China and India), the Middle East, Africa, and Canada.

Dr Verbois began her FDA career as a reviewer in CDER’s Office of New Drugs, where she supervised the evaluation of oncology drug applications leading to the initiation of clinical trials and the approval of life-saving, first-in-class therapies.

She holds a bachelor’s degree from Tulane University, a Ph.D. in Pharmaceutical Sciences from the University of Kentucky College of Pharmacy, and completed her postdoctoral training at the National Institutes of Health (NIH). Her career reflects a deep commitment to strengthening global regulatory systems and advancing access to safe, effective, and high-quality medicines worldwide.